Good luck to Rockefeller's Clare Cahir, Heloise Carion, Erika Layfield, Julia Losner, @daniel_s_oh, @ESeltzr, Taylor Wallace, and all other runners in the NYC Marathon this Sunday! 🏃🏽 🏃🏽♀️ 🏃🏽♂️
🚨Women with ER(–) breast cancer who took aprepitant (anti-nausea drug, NK1R blocker) had a 31% lower risk of metastasis or death (p<0.001) in large Norwegian study by Botteri & Chang. More doses = better survival 📉.Clinically validates our work by @VeenaPadmanaban: neuronal substance P drives BrCA metastasis via tumor NK1R & is blocked by aprepitant. https://t.co/lvxmFxA3g8. @RockefellerUniv@theNCI
Can aprepitant improve outcomes in TNBC?
In a cohort of 13,811 women, aprepitant use during chemo linked to:
📉34% ↓ distant recurrence (HR 0.66)
📉39% ↓ breast cancer mortality (HR 0.61)
👉 Especially in triple-negative breast cancer
🤔 Could this be due to better treatment continuation via improved tolerability?
Or is there a molecular mechanism—e.g., NK1R pathway involvement?
https://t.co/OaICDuNtv7
@OncLive@OncoAlert@SuyogCancer@Larvol
Lymphatic dysfunction in lupus contributes to cutaneous photosensitivity and lymph node B cell responses @jclinicalinvest@TheresaLuLab
https://t.co/khcLE0FMwu
EXCITED to share my PhD work in @CellCellPress. We found that the chance of developing metastasis is partly decided by the DNA we inherited. We identified a germline variant in PCSK9 present in 70% of the white women conferring higher risk of breast cancer metastasis. (1/9)
Good luck to Rockefeller's Marina Caskey (@marinacaskey1), Julia Losner, Brian Oh, Ethan Seltzer (@ESeltzr), Taylor Wallace, Mahsa Shirani Faradonbeh, and all other runners in the @nycmarathon this Sunday! 🏃🏽 🏃🏽♀️ 🏃🏽♂️
Imagine nerves as highways that help cancer cells spread, but a common anti-nausea drug can act like a roadblock to slow this down.
https://t.co/gRPrDxbKgB
@VeenaPadmanaban@SohailTavazoie@IsabelKel@ESeltzr @benostendorf
The sorts of nerve that allow people to touch, see, hear and taste can help breast cancer cells to infiltrate other regions of the body https://t.co/I5XBJpPIHZ
Researchers in @SohailTavazoie's lab found a “neuro-cancer axis” that may promote the spread of breast cancer. They also found that an FDA-approved anti-nausea medication may prevent it: https://t.co/vjnTds0yQy #RockefellerScience
Our paper in @Nature is out! We demonstrate that sensory neurons drive breast cancer metastasis via paracrine signaling mediated by substance-P. Fortunate to work with such a great team lead by @SohailTavazoie and @VeenaPadmanaban with support from @IsabelKel @benostendorf & more
🚨❗️🚨 New Paper Alert
My postdoctoral work now out in @Nature. We find that sensory neurons drive breast cancer metastasis via an activity-dependent paracrine signalling mechanism mediated by substance-P, extracellular ssRNA & TLR7 receptor. (1/11)
https://t.co/0eDdmLubGT$
🧵👇🏾
It's out! Our story shows that IFN inhibits Langerhans cell ADAM17 in photosensitivity and is a resource for transcriptomic profiles of non-lesional skin from 3 lupus models. Congratulations to Thomas, Victoria, Ethan and coauthors!
https://t.co/35wXgCvpdN
‼️We're thrilled to introduce the 8⃣ talented individuals who have matched into our @UCSFGSResidency as General Surgery Preliminary Interns - We're delighted to offer a heartfelt and eager welcome to each of you as you commence this enriching journey with us! #Match2024 🎉🥳
We’re thrilled to share that we’re launching a new @CZBiohub in New York!
Bringing together engineers + scientists at @Columbia, @RockefellerUniv and @Yale, #CZBiohubNY will engineer immune cells for earlier detection & treatment of disease
New preprint from @TheresaLuLab assessing the role of interferon acting on Langerhans cell ADAM17 in lupus photosensitivity! Thank you to all authors and collaborators involved for bringing this project to life: https://t.co/Y9KmE4b0C4 @VictoriaZyulina@ESeltzr@HSpecialSurgery
A better title for this article would be “Huge demand for PhD scientists leads many to land high-paying jobs in the biotech sector” https://t.co/RffVV8Y7XG